A Dengue Virus Serotype 1 mRNA-LNP Vaccine Elicits Protective Immune Responses
Abstract
With 400 million worldwide infections each year, dengue is the most common vector-borne viral disease. Forty percent of the world's population is at risk, with dengue experiencing consistent geographic spread over the years.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- May 24, 2021
- Source ID
- 10.1128/jvi.02482-20
Entities
People
- Amelia K Pinto
- Clayton J. Wollner
- James D Brien
- Justin M Richner
- Mariah A. Hassert
- Michelle Richner
Organizations
- Saint Louis University
- United States Department of Defense
- University of Illinois College of Medicine